By Dr. Shweta Agarwal, MBBS, DGO Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO Last updated: June 2026
Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.
Aansh Hospital & IVF Center is a government-registered Level-2 ART clinic (Reg. No. MH/AC/2024/15441/L2/Chandrapur/132), part of a growing chain of fertility centres across Vidarbha and northern Telangana, with our headquarters and in-house embryology lab in Chandrapur. Our government ART registration covers the full range of regulated fertility treatments including IVF and frozen embryo transfer. Endometrial assessment and uterine cavity evaluation are part of our routine work-up before every transfer cycle.
Many patients who come to us after a failed IVF cycle or a deferred transfer are told, for the first time, that their lining "wasn't thick enough." The phrase can sound alarming — as though the body is at fault in a fundamental way. In practice, a thin endometrium is a specific, investigable finding. Understanding what it means, why it happens, and what can be done about it is the first step to a clear plan.
This guide explains the endometrium's role in implantation, what "thin" means in clinical terms, how it is assessed, and what approaches are used to manage it. I have written it for anyone going through IVF or frozen embryo transfer in Vidarbha who wants to understand this part of their care in detail.
What is the endometrium and why does it matter for IVF?
The endometrium is the inner mucosal lining of the uterus — the surface to which an embryo must attach and implant to establish a pregnancy. Every month under the influence of oestrogen and progesterone, it thickens, develops a characteristic three-layer (trilaminar) structure, and enters a "window of implantation" during which it is receptive to an embryo.
In IVF, the embryo is transferred directly into the uterine cavity. For implantation to occur, the lining must be both thick enough and structurally receptive at the time of transfer. If it is not, even a good-quality embryo may fail to implant — not because of any problem with the embryo, but because the surface it lands on is not prepared to receive it. Endometrial receptivity is therefore one of the key variables in determining whether a transfer succeeds.
What thickness is considered "thin" for embryo transfer?
A thickness below approximately 7 mm on transvaginal ultrasound at the time of triggering (in a fresh cycle) or at the point of progesterone start (in a frozen embryo transfer cycle) is widely cited in the literature as a threshold of concern. However, evidence on the exact cutoff is debated — some studies use 6 mm, others 8 mm, and outcomes vary across populations and protocols. The 7 mm figure should be understood as a commonly used clinical reference point, not an absolute rule.
What is measured is not just the total thickness — which is the combined measurement of both layers of endometrium, taken in the long axis of the uterus on transvaginal ultrasound — but also the pattern. A trilaminar (three-line) appearance is associated with better receptivity than a homogeneous or hyperechoic pattern, even at the same thickness. Both the number and the appearance matter.
Practically speaking, if the lining is below approximately 7 mm on the day the decision is made about triggering or starting progesterone, most clinicians will consider deferring the transfer and investigating or optimising the lining rather than proceeding.
What causes a thin endometrium?
There are several recognised causes, and in some cases more than one may be present at the same time.
Prior uterine surgery or curettage is one of the most common causes. Procedures such as dilation and curettage (D&C) after a miscarriage or termination, myomectomy (fibroid removal), or repeated endometrial biopsy can cause scarring of the uterine lining. When scarring is extensive, it is called Asherman's syndrome (intrauterine adhesions) — a condition in which scar tissue partially or completely obliterates the uterine cavity, reduces endometrial volume, and impairs the normal cyclical growth of the lining.
Endometritis — chronic inflammation or infection of the endometrium — can impair receptivity even when routine imaging looks relatively normal. Chronic endometritis (CE) is often subclinical, meaning it causes no obvious symptoms, and is typically identified on endometrial biopsy or hysteroscopy with biopsy.
Reduced blood flow to the endometrium limits the delivery of oestrogen and nutrients the lining needs to grow. Reduced subendometrial blood flow can be related to structural factors (such as adenomyosis or previous surgery), systemic circulation, or idiopathic causes.
Low oestrogen levels directly impair endometrial proliferation. During a natural cycle or a stimulated IVF cycle, oestrogen drives thickening of the lining. If oestrogen is insufficient — whether because of poor ovarian response, premature ovarian insufficiency, or other factors — the lining may not reach an adequate thickness.
Prolonged clomiphene (clomifene) use is a well-recognised pharmacological cause. Clomiphene acts as an oestrogen antagonist at the level of the endometrium; with repeated cycles, it can produce a thin, less receptive lining even when ovulation is occurring normally. This is one reason that many clinicians move away from clomiphene after a limited number of cycles.
Idiopathic thin endometrium — where no specific cause is identified despite investigation — does occur and is one of the more challenging management scenarios. In Marathi, patients sometimes describe this frustration as पातळ गर्भाशयाचे अस्तर (a thin uterine lining) that "does not grow" despite treatment; it is a recognised clinical problem for which no single solution works universally.
How is a thin endometrium investigated?
The investigation starts with careful ultrasound assessment — transvaginal scanning is the standard method for measuring endometrial thickness and pattern. Serial scans during a monitoring cycle give information about how the lining grows in response to oestrogen over time, not just a single measurement.
Hysteroscopy is the key investigation for structural causes. A thin, rigid telescope is passed through the cervix into the uterine cavity under direct vision. This allows the surgeon to directly inspect the cavity wall, identify adhesions, scarring, polyps, fibroids distorting the cavity, or signs of inflammation. Hysteroscopy is both diagnostic and, when adhesions are found, immediately therapeutic — adhesions can be divided (adhesiolysis) at the same procedure.
Endometrial biopsy can be taken at hysteroscopy or as a separate outpatient procedure to assess for chronic endometritis. Histopathology showing plasma cells in the endometrial stroma is the hallmark finding of CE. Microbiological culture or molecular testing may also be used.
Hormonal assessment — including oestradiol levels during the monitoring phase — confirms whether adequate oestrogen stimulation is reaching the endometrium.
The sequence and extent of investigation depends on the individual history. A patient with a prior D&C and a lining that has never been seen above 5 mm will be investigated differently from someone whose lining reached 8 mm in prior cycles but has fallen in the current one.
What are the management approaches for a thin endometrium?
There is no single, universally effective treatment for a thin endometrium. Management is tailored to the likely cause and may involve more than one approach.
Oestrogen optimisation is the foundation of management in most cases. Extended or higher-dose oestrogen supplementation — administered orally, vaginally, or transdermally (patch) — can improve lining growth in many patients. The route and dose are adjusted based on serial ultrasound monitoring. There is no evidence that any one route is universally superior — the response is individual.
Treating endometritis with appropriate antibiotic therapy (typically guided by the organisms found on biopsy and culture) can lead to significant improvement in endometrial receptivity in patients whose CE was previously unrecognised. A repeat biopsy after treatment confirms resolution before proceeding to transfer.
Hysteroscopic adhesiolysis for Asherman's syndrome involves surgically dividing adhesions to restore the uterine cavity. This may need to be done in stages for moderate or severe disease, with oestrogen support between procedures. The degree of recovery depends on the extent of scarring — partial restoration is common; complete restoration of normal endometrial function is the goal but may not always be achievable.
A freeze-all strategy with a dedicated frozen embryo transfer (FET) cycle is one of the most practical approaches available in IVF when lining quality is a concern. Rather than transferring on the same stimulation cycle — where lining growth may have been suboptimal — all embryos are frozen at blastocyst stage, and the transfer is deferred to a separate, carefully monitored cycle in which the lining can be prepared and optimised under controlled conditions. This is a well-established pathway and is the primary way Aansh supports patients whose lining needs more preparation time. See our frozen embryo transfer guide for how an FET cycle is structured.
Adjunct approaches — including vasodilators (such as low-dose aspirin, sildenafil, pentoxifylline), granulocyte colony-stimulating factor (G-CSF) infusion, and platelet-rich plasma (PRP) intrauterine instillation — are used in some centres for refractory thin endometrium. The evidence for these interventions is mixed and limited — some small studies report benefit, but robust randomised trial data are lacking. These are considered in selected cases where standard approaches have not produced an adequate lining, not as first-line management. Overstatement of their effectiveness would not serve patients well; they are investigational tools in a difficult clinical scenario.
The key reassurance is this: a thin endometrium is not a fixed, permanent state in most cases. It is an investigable finding, and deferring transfer until the lining is optimal — even if that requires additional investigation and preparation time — is a reasonable and clinically appropriate strategy.
When can transfer proceed and what monitoring is used?
The decision to proceed with an embryo transfer is made on the basis of serial ultrasound monitoring of the lining during the preparation cycle. Scans are typically performed every few days during the proliferative phase to track thickness and pattern.
Most clinicians look for a lining that has reached the threshold they consider adequate for that patient and has developed a trilaminar pattern before committing to the progesterone start date. Progesterone converts the lining from proliferative to secretory phase and opens the implantation window — timing this correctly relative to lining readiness is important.
If the lining does not reach the target threshold by the end of the oestrogen phase despite optimisation, the cycle may be cancelled and the embryo(s) remain safely frozen for a future attempt. While cancellation is disappointing, it is always preferable to transferring into a lining that is unlikely to support implantation.
Your transfer coordinator and Dr. Shweta Agarwal will explain exactly what monitoring schedule and threshold apply to your specific situation at Aansh's fertility assessment consultation.
How does thin endometrium relate to recurrent implantation failure?
Recurrent implantation failure (RIF) — typically defined as failure of two or more good-quality embryo transfers — has multiple possible causes, and a persistently thin or poorly receptive endometrium is one of them. In patients presenting with RIF, uterine factor investigation (hysteroscopy, endometritis testing) is a standard part of the diagnostic work-up alongside assessment of embryo quality and thrombophilia screening.
Not every case of thin endometrium leads to RIF, and not every case of RIF is caused by a thin endometrium. However, identifying and addressing a uterine lining problem before further transfers are attempted is a logical and evidence-based step. Patients with recurrent pregnancy loss may also benefit from endometrial evaluation as part of their investigation. Our unexplained infertility page addresses situations where the cause is not yet identified.